Dr. Rohini Manaktala, DO

Dr. Manaktala practices at Memorial Hermann Medical Group in Wharton, Texas.

Dr. Manaktala's NPI, 1508253402, was assigned on April 20, 2015. Dr. Manaktala graduated from Edward Via College of Osteopathic Medicine - Blacksburg in 2015. Dr. Manaktala holds Texas license T5383.

Dr. Manaktala's primary practice is Memorial Hermann Medical Group, at 2100 Regional Medical Dr, Wharton, TX 77488 in Wharton County. The practice phone is (281) 325-4100.

Dr. Manaktala's primary practice is Memorial Hermann Medical Group in Wharton, Texas. Dr. Manaktala is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is Memorial Hermann Medical Group. Dmand AI also links Dr. Manaktala to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manaktala practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Manaktala's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Manaktala is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Manaktala is licensed in Texas.

Dmand AI lists angioplasty, cardiac catheterization and endocarditis among the conditions Dr. Manaktala treats.

CMS data shows 543 Medicare services from Dr. Manaktala across 13 procedure codes in 2024, for 197 Medicare patients. Medicare paid $41,100 for them.

CMS counts 197 Medicare patients who saw Dr. Manaktala in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Manaktala's median patient age at 65, with 63% women.

In 2024, Dr. Manaktala wrote 401 Medicare Part D claims for 91 patients. 87% of them were for generic drugs. CMS names the drug for 291 of them, across 10 drugs with 11 or more claims each, at $28,476 in total drug cost. In 2023, CMS named 173 claims across 8 drugs.

Dr. Manaktala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Manaktala as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Manaktala, published from 2016 to 2020. Dr. Manaktala's most frequent co-authors are Anil Shankar Magge, MD and Ann Palmer, MD.

CMS Open Payments shows 221 general payments to Dr. Manaktala from 41 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 87% of the total. AstraZeneca Pharmaceuticals LP paid the most, $870.

Dr. Manaktala graduated from Edward Via College of Osteopathic Medicine - Blacksburg in 2015.

Dr. Manaktala is in network with 20 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.